AZ Finds New CMO
August 25, 2015.
Genentech's former senior vice president of early development Dr Sean Bohen will join AstraZeneca (AZ) as chief medical officer and executive vice president of global medicines development, effective September 15.
AZ chief Pascal Soriot said Bohen's "extensive diagnostics experience will also reinforce our efforts in precision medicine.”
Before joining Genentech, Bohen was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the National Cancer Institute.
AZ's former CMO, Briggs Morrisson, left the company in June to join the small, privately owned US biotech, Syndax Pharmaceuticals (Waltham, MA).
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
